News Detail
Copenhagen, 9 Dec 2020: Cancer patients who took immune therapies such as Merck & Co.’s Keytruda or Bristol-Myers Squibb Co.’s Opdivo showed a greater risk of developing heart problems in a View Details
Source : Hindustan Times
Related News
- Researchers create new tool for assessing risk of kidney injury after chemotherapy (29-03-2024)
- Researchers create new platform to identify proteins for targeted treatment of disease (24-03-2024)
- T1-spanin breakthrough offers new hope against antibiotic resistance (14-03-2024)
- IIT Kanpur researchers unveil new insights into working mechanism of cholesterol lowering drugs (14-03-2024)
- Scientists have identified new antiviral drugs effective against COVID (12-03-2024)
- U-M researchers open new leads in anti-HIV drug development, using compound found in nature (10-03-2024)
- CDRI Lucknow develops oral pill to cure fractures (08-03-2024)
- Drug Interactions Predicted with Tissue Model/Machine Learning Combo (04-03-2024)
- MBL Team finds Novel Vehicle for Antibiotic Resistance (02-03-2024)
- Blindness from some inherited eye diseases may be caused by gut bacteria (27-02-2024)